# Scanbase **Source:** https://geo.sig.ai/brands/scanbase **Vertical:** Healthcare **Subcategory:** General **Tier:** Emerging **Website:** scanbase.com **Last Updated:** 2026-04-14 ## Summary Computer vision API reading at-home lateral flow test photos for 40+ test types; $3M revenue with 5-person team enabling telehealth result verification for COVID, flu, and STD tests. ## Company Overview Scanbase is a healthcare technology company providing a computer vision API that enables medical and consumer health companies to analyze at-home diagnostic test results through smartphone photos — reading lateral flow tests (the strip-based rapid tests used for COVID-19, flu, RSV, strep, pregnancy, and STDs) and returning structured results that can be recorded in health apps, telehealth platforms, and clinical systems. Founded in 2022 in San Francisco and a Y Combinator W23 graduate, Scanbase raised $2.5 million from Dupe Ventures and Liquid 2 Ventures, achieving $3 million in revenue in 2024 with a 5-person team.\n\nScanbase's API integrates into health apps, telehealth platforms, and employee health programs — when a user takes a photo of their at-home test strip, the API analyzes the image to detect control line and test line presence/intensity, returning a validated result (positive, negative, invalid) with confidence scores. This replaces manual result entry (prone to misinterpretation) and photo review by human staff with automated, consistent computer vision interpretation. The API covers 40+ test types including COVID-19, flu A/B, RSV, pregnancy, and various STD tests.\n\nIn 2025, Scanbase competes in the digital diagnostics and at-home testing technology market with Sight Diagnostics, LumiraDx, and platform-specific solutions built by major diagnostics companies for at-home test result interpretation. The COVID-19 pandemic permanently expanded at-home testing adoption, creating a large installed base of consumers comfortable with lateral flow tests and a growing need for digital result capture and verification in telehealth workflows. The $3M ARR with a 5-person team demonstrates exceptional capital efficiency. The 2025 strategy focuses on expanding the test coverage library, growing integrations with telehealth and employee health platforms, and adding verification workflows for use cases where authenticated test results are needed (insurance claims, return-to-work programs). ## Frequently Asked Questions ### What is Scanbase? Scanbase is a healthcare technology company that provides a smartphone computer vision API for analyzing at-home diagnostic test results. Founded in 2022 and based in San Francisco, the company enables medical companies to automatically analyze tests for COVID-19, FLU, RSV, STD, and other conditions through their API platform. ### What products and services does Scanbase offer? Scanbase offers a diagnostic test API that converts smartphone photos of at-home tests into accurate results. Their comprehensive catalog supports 40+ lateral flow colorimetric tests, enabling automated analysis of various diagnostic tests including COVID-19, FLU, RSV, and STD tests. ### Who are Scanbase's target customers? Scanbase targets medical companies and healthcare providers who need automated at-home diagnostic test analysis solutions. Their API is designed for organizations looking to improve test result confidence through smartphone-based analysis. ### When was Scanbase founded? Scanbase was founded in 2022. The company participated in Y Combinator's Winter 2023 batch. ### Where is Scanbase located? Scanbase is based in San Francisco, California, USA. ### How much funding has Scanbase raised and from whom? Scanbase has raised $2.5 million in funding. The investors include Dupe Ventures, Leonis Investissement, Liquid 2 Ventures, and Lobster Capital. ### What are Scanbase's key achievements and metrics? Scanbase achieved $3 million in revenue in 2024 with a lean team of 5 employees. The company has built a comprehensive catalog of 40+ test types and successfully raised $2.5 million in funding. ### What technology does Scanbase use? Scanbase uses smartphone computer vision technology to analyze at-home diagnostic test results. Their API processes photos of lateral flow colorimetric tests and converts them into accurate diagnostic results, addressing test result confidence through automated smartphone-based analysis. ### Who founded Scanbase? Scanbase was founded by Jeffrey Lange, a Rhode Island School of Design graduate, and Steve Roger, who studied Computer Science at UC Berkeley and is a LinkedIn veteran. ### What types of diagnostic tests does Scanbase support? Scanbase supports 40+ lateral flow colorimetric tests in their comprehensive catalog. This includes tests for COVID-19, FLU, RSV, and STD, among other at-home diagnostic tests. ## Tags healthtech, saas, ai-powered, analytics, mobile-first, north-america, b2b --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*